🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Groundbreaking work on a very promising new antifungal. Free access here: authors.elsevier.com/c/1lHca5E-Uo...

🚨Our latest review in Thorax about the impact of climate change focusing on fungal pathogens in Europe 🌍 A truly enjoyable collaboration with Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social and @mbottery.bsky.social thorax.bmj.com/content/earl...

Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge @grthompsonmd.bsky.social and Angel Desai www.nejm.org/doi/full/10....

Climate change: shifting boundaries of fungal disease in Europe and beyond New review in Thorax by @mbottery.bsky.social Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social @normanvanrhijn.bsky.social thorax.bmj.com/content/thor... #MedSky #IDSky #PulmSky #ClimateSky #MedMycoSky

Diagnosis and Management of Candida Endophthalmitis and Chorioretinitis Nate Permpalung, Sarah Sedik, Pete Pappas, @martinhoenigl.bsky.social, @drluiso.bsky.social in @cmijournal.bsky.social www.clinicalmicrobiologyandinfection.com/article/S119...

Proud to present the progress of ECMM Candida IV study at #ISHAM2025 Still open for participation! @martinhoenigl.bsky.social

Yesterday at ISHAM 2025, Danila Seidel explored how environmental extremes can spark fungal outbreaks 🌪️🌱 A powerful reminder of climate’s role in emerging mycoses. #ISHAM2025 #FungalOutbreaks #ClimateAndHealth #MedicalMycology

Did you know..75% of wine has significant levels of azole antifungals in it? (German wine anyway) Potential consequences for driving resistance... #IDSky #ISHAM

Happy to meet some wonderful colleagues & brilliant minds in Medical Mycology. @martinhoenigl.bsky.social @germhuntermd.bsky.social at #ISHAM2025 It has been an amazing congress with enriching academic sessions, lovely food & great hospitality at such a captivating location @fozdoiguacu.bsky.social

Thrilled to see Dr. Jon Salmanton-García receive the GEMICOMED Young Researcher Award 2025! His impactful research on invasive fungal & viral infections in hematologic malignancies is shaping the future of mycology: www.journalofinfection.com/article/S016... #FungalResearch #Mycology

Exciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: www.ecmm.info/working-grou... @martinhoenigl.bsky.social

Sampling different types of grains at local markets in Namibia starting our project Fungal diversity of processed staple cereals from rural subsistence farming communities in Namibia 🙏🏻🙏🏻to colleagues from University of Namibia for hosting me

Honored to present today at ESCMID Global in Vienna: Ibrexafungerp salvage results from 233 patients in the FURI study — showing high success rates! 🔬💪 A promising new tool in the antifungal pipeline. #ESCMID2025 #FURIstudy #Ibrexafungerp #Antifungals #InfectiousDiseases

ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @martinhoenigl.bsky.social

👉Participate in the ECMM Candida IV Study 🌍wide study on candidemia caused by non-albicans Candida Requirement: clinical data & isolate (not req for C.auris) Observation period: 04/2024 - 09/2025 Interested? Email [email protected]

On April 1, 2025, our project officially started. A significant milestone that we have worked towards for a long time. Now, we look forward to taking the next steps together. @martinhoenigl.bsky.social @simonfeys.bsky.social @agocarvalho.bsky.social

Projekt „GALActIC“ startet: Biomarker für Pilzinfektionen erforscht www.medunigraz.at/news/detail/...

🔬💡 ICVS Researchers Join Innovative GALActIC Study to Combat IAPA! Researchers of the I3D team are part of this European project, aiming to improve the identification and treatment of Influenza-associated Pulmonary Aspergillosis and enhance patient care! 🙌 More at: icvs.uminho.pt/icvs-researc...

A potentially new antifungal class: Mandimycin, polyene-like but targeting phospholipids, rather than ergosterol. ✅activity against yeasts in vivo 🐁 With insights from @olivercornely.bsky.social @martinhoenigl.bsky.social & David Denning www.science.org/content/arti...

Deadly fungi are becoming drug-resistant. A new compound could beat them | Science | AAAS @kakape.bsky.social www.science.org/content/arti...

🔬 New research highlights a potential game-changer in treating invasive mould infections! 🦠 Patients show increased PD-1 expression, suggesting immune checkpoint inhibitors could help fight these deadly infections. More studies needed! 💡 onlinelibrary.wiley.com/doi/10.1111/... #Immunotherapy

New Medical Study Starting Soon 🔬 The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik. Follow us for more! @martinhoenigl.bsky.social @agocarvalho.bsky.social @simonfeys.bsky.social

Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter PK study for Screening Antifungal Exposure in Intensive Care Units (SAFE-ICU) J Roberts etc TLDR: ++variable, need tailored approach w TDM link.springer.com/article/10.1...

🌍 Fungal Care Gaps: Brazil vs. Europe 🇧🇷➡️🇪🇺 Fungal infections are a global challenge with uneven access to diagnostic and treatment. Europe has more labs, better tests, and antifungal access, while Brazil faces greater threats from Cryptococcus and Histoplasma. journals.asm.org/doi/epub/10....

It’s out! A pleasure to work with @alukmd.bsky.social on the latest #fungal update of the ID Clinics of North America. I rembember saving money as a med student to buy them… #FullCircle #IDSky #MedSky

Prevalence of injecting-related bacterial and fungal infection among people who inject drugs: a systematic review and meta-analysis ✅ Just Accepted #IDSky

Despite being vastly outnumbered by bacteria, fungi in our microbiome still play a significant role in our health. In today’s episode, we learn about the “mycobiome.” Plus, turmoil at the NIH. Listen here 🎧: buff.ly/4ii9d2g

Antifungal pipeline: New tools for the treatment of mycoses. Focus on LMICs where many dont have access to current antifungals. Updated maps on fungal availability in LMICS. Thanks to a fantastic group of authors www.sciencedirect.com/science/arti...

Fungal Infections in People Who Use Drugs Jose Portugal Gonzales & @drluiso.bsky.social academic.oup.com/ofid/advance...

📢 New article! 🦠 Insights on tackling Candida infections, rising antifungal resistance, and evolving treatment strategies. Immediate action is key! Read more: www.contagionlive.com/view/address... #Candida #InfectiousDiseases #AntifungalResistance

New guidelines for diagnosis and management of candidiasis from ECMM in cooperation with @ishamycology.bsky.social and @asm.org Led by @olivercornely.bsky.social & @rosannesprute.bsky.social with contributions from >100 experts Reposting with algorithms 🔓🔗: authors.elsevier.com/sd/article/S...

Ramage et al. (2025) discuss fungal biofilms' rising clinical impact, highlighting their resistance to treatment and need for new strategies like novel antifungals, nanotech, and biofilm-disrupting agents.

It’s here! Truly epic work from the @unicologne.bsky.social team! Honored to have been part of this project.

New guidelines for diagnosis and management of candidiasis from ECMM in cooperation with @ishamycology.bsky.social and @asm.org Led by @olivercornely.bsky.social @rosannesprute.bsky.social with contributions from >100 experts Author link: authors.elsevier.com/sd/article/S... #IDSky

Global guideline for the diagnosis and management of candidiasis: ECMM @youngecmm.bsky.social in cooperation with @ishamycology.bsky.social & ASM. Big congrats to @olivercornely.bsky.social & @rosannesprute.bsky.social for leading this tremendous team www.sciencedirect.com/science/arti...

Super happy to be part of this team investigating genetics in influenza-associated aspergillosis! Now we just need a logo…

Would global warming bring an increase of invertebrate-associated cutaneous invasive fungal infections? Kontoyiannis & Casadevall journals.asm.org/doi/10.1128/...

Warmer climates could supercharge fungal diseases transmitted by insects. pubmed.ncbi.nlm.nih.gov/39907444/

Kickoff meeting for the 🌌Galectin-3 targeted antifungal prophylaxis in ICU influenza (GALActIC)🌌 eppermed.eu project at UZLeuven Incredibly productive meeting with the Galactic team @agocarvalho.bsky.social @simonfeys.bsky.social @msgerc.bsky.social @ishamycology.bsky.social

Pulmonary Co-Infection of Pneumocystis jirovecii and Aspergillus species Hatzl and colleagues in @ofidjournal.bsky.social academic.oup.com/ofid/advance...

Nice overview of the problems we face when tackling fungal infections and how climate change might exacerbate them. With quotes from myself and @martinhoenigl.bsky.social #immunosky #microsky 🧪 www.dailymail.co.uk/sciencetech/...

Posaconazole for Prevention of COVID-19-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case–Control Study (POSACOVID) onlinelibrary.wiley.com/doi/full/10....

When you think of Aspergillus, you think of potentially-fatal disease in SCT or CGD patients. This Aspergillus may be going for the ovaries 😳 Aspergillus tubingensis in patients with polycystic ovary syndrome (PCOS) & mice with PCOS-like disorder www.cell.com/cell-host-mi...

Emerging #Sporothrix brasiliensis is fueling a cat-transmitted sporotrichosis #outbreak in Northeast Brazil. Over 1,100 cases identified in Recife's metro region (2016-2021), with zoonotic transmission linked to Rio de Janeiro strains. Link: link.springer.com/article/10.1... #PublicHealth #Zoonoses

Predictors of Cryptococcus gattii clinical presentation and outcome: An international study doi.org/10.1093/cid/...

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy @springernature.bsky.social #Mycopathologia link.springer.com/content/pdf/...

Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis Stefan Hatzl, et al. Clinical Infectious Diseases, ciae633, doi.org/10.1093/cid/...

Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV – A systematic review and network meta-analysis of randomized controlled trials Hatzl et al TLDR: “no clear best choice” www.clinicalmicrobiologyandinfection.com/article/S119...

Looking for medical mycology content? Check out accounts in the Medical Mycology starter pack: go.bsky.app/8XGywEx and check out (and pin) the new MycoSky feed for all things medical mycology bsky.app/profile/did:...